Health Care
Pfizer secures FDA approval for oncology biosimilar Zirabev; stock gains
A day after appointing former FDA chief Scott Gottlieb to its board of directors, pharma giant Pfizer (PFE) said it…
What the future holds for generic drug industry
The size of the generic drug market in the US is so large that about 90% of all prescription medicines…
M&A alert: AbbVie agrees to acquire Allergan for $63 billion
Confirming reports published by Wall Street Journal earlier today, pharmaceutical giant Abbvie (NYSE: ABBV) said it would acquire Irish competitor…
Bristol-Myers lets go of psoriasis drug to save Celgene merger; stock falls
The planned merger between pharmaceutical firms Bristol-Myers Squibb Company (NYSE: BMY) and Celgene (CELG) - touted as a landmark deal…
DEEP FOCUS: Everything you need to know about GW Pharmaceuticals
Shares of GW Pharmaceuticals (NASDAQ: GWPH) have gained 72% in the year-to-date period, emerging as a new favorite among pot…
Ocular Therapeutix gains after FDA approves eye drug for additional indication
Ocular Therapeutix (Nasdaq: OCUL) staged a dramatic recovery Friday after receiving the FDA’s green signal for its ophthalmic drug DEXTENZA…
Chevron Phillips Chemical is looking to acquire Nova Chemicals
Chevron Phillips Chemical Company, a joint venture between Chevron Corp. (NYSE: CVX) and Phillips 66 (NYSE: PSX) is reportedly looking…
Earnings: Canopy Growth posts big Q4 miss, but investors remain stoic
Canopy Growth (NYSE: CGC) reported a loss of CAD 0.98 per share on revenues of CAD 94.1 million in the…